Last reviewed · How we verify

NCT04443595

Dual-scopic Pancreatic Necrosectomy (DPN)

Status unknown NA Last updated 23 June 2020
What this trial tests

NA trial testing Dual-scopic pancreatic necrosectomy(DPN) in Pancreatitis in 20 participants. Status unknown.

Timeline
1 July 2020
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorFirst People's Hospital of Hangzhou
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment20
Start date1 July 2020
Primary completion31 December 2025
Estimated completion31 December 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

First People's Hospital of Hangzhou

Who can join

18 and older, any sex, with Pancreatitis or Pancreatitis, Acute Necrotizing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The LPN procedure is performed under general anesthesia. The transperitoneal access to peripancreatic space is via the gastro-colic ligament and greater omentum, effusion and pus is removed by laparoscopic forceps and suction. Laparoscopic cholecystectomy (LC) is performed during the LPN procedure on patients with indication. The NPN procedure is followed by the standard retroperitoneal approach. After the catheter is exchanged over a guide wire and serially dilated up from 6F to 24F followed by Seldinger technique, the access track to the necrotic cavity is established. A nephroscope is inserted into the cavity through the track for debridement. Using forceps and suction, the peripancreatic solid necrotic tissue and pus is grasped and removed. A large-bore irrigating drain is left in the cavity, with continuous irrigation by warm normal saline solution at a rate of 100-125 ml/h after surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pancreatitis

Currently open trials in the same condition.

Other First People's Hospital of Hangzhou trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04443595.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing